Recorded as renamed to Covidien LP (2012)
16 patents currently held
342 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
3 more records may belong here and await a decision; they are not counted.
The next term ends in Feb 2029. from the record
Of the 342 now held by other companies, 315 name Covidien LP as their current owner, and 27 more name another party. Each row says which.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
7
Ending by 2030
Feb 2029
Next term end
16
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Mar 2029 · Medium confidence
Also notable
Ends no later than Feb 2034 · Low confidence
Also notable
Ends Jun 2033 · High confidence
Also notable
Ends Jan 2031 · High confidence
Also notable
Ends Oct 2033 · High confidence
Also notable
Ends Jul 2031 · High confidence
Also notable
Ends Feb 2029 · High confidence
Also notable
Ends Oct 2029 · High confidence
Leak-Compenstated Proportional Assist Ventilation
US 8,448,641
The most cited patent in this portfolio, cited by 98 later US patents, top 10% of utility patents granted in 2013 in our data. Protection runs to 2029. A terminal disclaimer caps this term to an earlier patent's.
Systems and Methods for Determining Respiration Information Using Phase Locked Loop
US 10,376,157
Cited by 13 later US patents, top 25% of utility patents granted in 2019 in our data. Protection runs to 2034. A terminal disclaimer is on file and its reference is not resolved, so no cap is applied and the date may move earlier, never later.
System and Method for Storing and Providing Patient-Related Data
US 9,192,330
Cited by 33 later US patents, top 25% of utility patents granted in 2015 in our data, and renewed at every maintenance window due so far. Protection runs to 2033.
Retinopathy of Prematurity Determination and Alarm System
US 8,428,677
Cited by 80 later US patents, top 10% of utility patents granted in 2013 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2031. A terminal disclaimer caps this term to an earlier patent's.
System, Method, and Software for Automating Physiologic Displays and Alerts with Trending Heuristics
US 9,585,565
Cited by 45 later US patents, top 10% of utility patents granted in 2017 in our data, and renewed at every maintenance window due so far. Protection runs to 2033.
Methods and Apparatus for Determining Breathing Effort Characteristic Measures
US 9,011,347
Cited by 32 later US patents, top 25% of utility patents granted in 2015 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2031.
System and Method for Evaluating Physiological Parameter Data
US 8,781,753
Renewed at every maintenance window since the 2014 grant; no more fees are due before its term ends in 2029.
Method for Detection of Aberrant Tissue Spectra
US 9,801,584
Granted 2017 and renewed at every maintenance window due so far. Protection runs to 2029.
Formerly held, still cited
Notable
Ends Mar 2030 · High confidence
Cited by 487 later US patents, top 1% of utility patents granted in 2011 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2030.
now held by Covidien LP
Also notable
Ends Nov 2031 · High confidence
Cited by 144 later US patents, top 5% of utility patents granted in 2014 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2031.
now held by Covidien LP
Also notable
Ends no later than Aug 2028 · Medium confidence
Cited by 81 later US patents, top 10% of utility patents granted in 2013 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2028. A terminal disclaimer is on file and its reference is not resolved, so no cap is applied and the date may move earlier, never later.
now held by Covidien LP
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Feb 13, 2027The maintenance fee for Systems and Methods for Determining Respiration Information Using Phase Locked Loop (US 10,376,157) comes due Feb 13, 2027. Unpaid by Aug 13, 2027, it lapses early.
- 1 fee due May 24, 2027The maintenance fee for System and Method for Storing and Providing Patient-Related Data (US 9,192,330) comes due May 24, 2027. Unpaid by Nov 24, 2027, it lapses early.
Recent changes
- 13 terms have ended since Aug 22, 2026
- Nov 20 US D671,125 Display Screen with a Graphical User Interface · term ended
- Nov 20 US 7,455,063 Adjustable Gas Delivery Mask Having a Flexible Gasket · term ended
- Nov 16 US 7,392,075 Method for Enhancing Pulse Oximetry Calculations in the Presence of Correlated Artifacts · term ended
- Nov 2 US 7,369,757 Systems and Methods for Regulating Power in a Medical Device · term ended
- Oct 21 US 8,866,592 Method for Detecting and Communicating with RFID Memory Devices · lapsed on the fee record
- Sep 30 US 8,844,526 Methods and Systems for Triggering with Unknown Base Flow · lapsed on the fee record
- Sep 29 US 8,160,726 User Interface and Identification in a Medical Device System and Method · term ended
- Sep 29 US 7,794,266 Device and Method for Reducing Crosstalk · term ended
- Sep 29 US 7,658,652 Device and Method for Reducing Crosstalk · term ended
- Sep 29 US 7,476,131 Device for Reducing Crosstalk · term ended
- Sep 21 US 7,487,773 Gas Flow Control Method in a Blower Based Ventilation System · term ended
- Sep 9 US 8,826,907 Systems and Methods for Determining Patient Effort And/Or Respiratory Parameters in a Ventilation System · lapsed on the fee record
- Aug 26 US 8,818,476 Reflectance and/or Transmissive Pulse Oximeter · lapsed on the fee record
What they patent
The largest of its 16 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Systems and Methods for Determining Respiration Information Using Phase Locked Loop | 1 in force | to Feb 2034 |
| System and Method for Storing and Providing Patient-Related Data | 1 in force | to Jun 2033 |
| Pathlength Enhancement of Optical Measurement of Physiological Blood Parameters | 1 in force | to Feb 2033 |
| Systems and Methods for Determining Oxygen Saturation | 1 in force | to Jun 2032 |
| Systems And Methods For Estimating Values Of A Continuous Wavelet Transform | 1 in force | to Jan 2030 |
| Method for Detection of Aberrant Tissue Spectra | 1 in force | to Oct 2029 |
| Systems and Methods for Monitoring Heart Rate and Blood Pressure Correlation | 1 in force | to Sep 2029 |
| Leak-Compenstated Proportional Assist Ventilation | 1 in force | to Mar 2029 |
| System and Method for Evaluating Physiological Parameter Data | 1 in force | to Feb 2029 |
Patents held now
Soonest term end first.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,781,753 | System and Method for Evaluating Physiological Parameter Data held by Covidien LP In force · High confidence | In force | High confidence | |
| US 8,448,641 | Leak-Compenstated Proportional Assist Ventilation held by Covidien LP In force · Medium confidence | In force | Medium confidence | |
| US 8,932,219 | Systems and Methods for Monitoring Heart Rate and Blood Pressure Correlation held by Nellcor Puritan Bennett Ireland In force · Medium confidence | In force | Medium confidence | |
| US 9,801,584 | Method for Detection of Aberrant Tissue Spectra held by Covidien LP In force · High confidence | In force | High confidence | |
| US 8,954,127 | Systems And Methods For Estimating Values Of A Continuous Wavelet Transform held by Nellcor Puritan Bennett Ireland In force · Low confidence | In force | Low confidence | |
| US D753,817 | Tracheostomy Tube held by Covidien LP In force · High confidence | In force | High confidence | |
| US D753,818 | Tracheostomy Tube held by Covidien LP In force · Medium confidence | In force | Medium confidence | |
| US 8,428,677 | Retinopathy of Prematurity Determination and Alarm System In force · High confidence | In force | High confidence | |
| US 9,011,347 | Methods and Apparatus for Determining Breathing Effort Characteristic Measures held by Nellcor Puritan Bennett Ireland In force · High confidence | In force | High confidence | |
| US 10,265,005 | Systems and Methods for Determining Oxygen Saturation held by Nellcor Puritan Bennett Ireland In force · Medium confidence | In force | Medium confidence |
Also on record, not counted in the 16: 342 patents in force now held by others · 389 patents ended · 5 applications pending · 281 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.